Scientists have identified a remarkable protein switch that influences whether cells burn fat or store it. Disabling this protein increases fat consumption and interferes with the formation of new fat cells, raising the possibility of a different approach to treating obesity. Subsequent research has strengthened the discovery, revealing that the same protein helps regulate how much energy the body burns.
What if one of the keys to fighting obesity lies not in suppressing appetite, but in changing how the body's cells use energy? Researchers at the Weizmann Institute of Science have identified a protein called MTCH2, nicknamed "Mitch," that plays an important role in controlling metabolism. When scientists disabled this protein in laboratory experiments, cells began consuming more fuel, including fats and carbohydrates.
They also found that removing Mitch could interfere with the process through which immature cells develop into fat cells. The discovery builds on earlier experiments in mice, in which switching off Mitch in muscle tissue increased energy expenditure, improved endurance, and protected the animals from diet-related obesity. The findings, published in The EMBO Journal in January 2025, suggest that manipulating this protein could eventually offer a way to influence both fat burning and fat accumulation.
Additional research published later that year has provided further evidence of its importance in regulating body fat and metabolism. Why Scientists Are Searching for Better Obesity Treatments Over the past decade, medications designed to promote weight loss have transformed obesity treatment. Drugs such as semaglutide and tirzepatide have helped many patients achieve substantial reductions in body weight, largely by influencing appetite and the body's responses to food.
But losing weight does not necessarily mean losing only fat. Weight reduction can also involve a decline in lean body mass, which includes muscle and other tissues. Preserving muscle is especially important because it supports strength, mobility, and metabolic health.
A 2026 analysis of 20 clinical trials involving 15,782 participants found that lean mass accounted for approximately 25% to 39% of the weight lost with several widely used weight-loss medications. Importantly, the researchers found that comparable proportional losses also occurred with lifestyle interventions, while adding resistance training helped preserve more lean tissue. These concerns have encouraged scientists to investigate ways to reduce body fat while protecting the muscles needed for long-term health.
Extract — continue reading at the source.
